Local Storage seems to be disabled in your browser.
For the best experience on our site, be sure to turn on Local Storage in your browser.

Difosfonal 300 mg 6 x 10 ml

Nr.
33090
Brand:
SPA - Società Prodotti Antibiotici
Batch:
2101
Expiry date:
30-Jun-2024
Registration number:
IT: A.I.C.: 026510038

Is the registration number of your country not listed? Then this product falls within the cascade control system.

Clodronic acid

More info

Disclaimer: Product in the photo may differ from the actual product.

DIFOSFONAL 300 mg / 10 ml concentrate for solution for infusion

Therapeutic Indications:

  • Tumor Osteolysis.
  • Multiple myeloma.
  • Primary hyperparathyroidism.
  • Prevention and treatment of postmenopausal osteoporosis.

Pharmacotherapeutic group: Drugs affecting bone structure and mineralization.

Clodronate is mainly excreted by the kidneys. Therefore, during the treatment with clodronate it is necessary to ensure adequate moisture absorption.

Instructions for use

DIFOSFONAL 300 mg / 10 ml concentrate for solution for infusion contains 54 mg sodium per dose. This medicine is for intravenous use only.
This should be taken into account when administering to patients with reduced kidney function or on a controlled sodium diet.

Clodronate disodium (Clodronic acid disodium salt) - 300mg / 10ml concentration for infusion solution

 

Veterinary advice

DIFOSFONAL is not recommended during pregnancy.

© 2022 Grovet B.V. All rights reserved.